Buy & Sell Corsair Gaming Inc (CRSR) – Corsair Gaming Inc Price Today
Aura AI Summary
Key Stats
- $956.60MMarket Cap
- TechnologySector
- -30.89%3M Drawdown
- $1.03BEnterprise Value
- -Dividend Yield
- 18 daysTypical Hold Time
Corsair Gaming Inc (CRSR) is currently valued at a market capitalization of $956.60M, with an enterprise value of $1.03B. Over the past 52 weeks, Corsair Gaming Inc has traded between a low of $4.58 and a high of $12.14, highlighting its annual price range. Over the past three months, Corsair Gaming Inc has recorded a drawdown of -30.89%, reflecting recent price volatility. On average, investors hold Corsair Gaming Inc for approximately 18 days, indicating typical investor behavior on the platform.
About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Most Recent News
Medical alert systems market to grow to $23.5B by 2035 driven by aging population and tech advances
The global medical alert systems market is projected to grow from $10.5 billion in 2025 to $23.5 billion by 2035, at a CAGR of 8.45%. Growth is fueled by an increasing elderly population preferring to age in place and advances in mobile and standalon...

Helium market to reach $8.59B by 2035 driven by MRI and semiconductor demand growth
The global helium market, valued at $5.03 billion in 2025, is projected to grow to $8.59 billion by 2035 with a CAGR of 5.47%. Growth is fueled by rising demand in healthcare for MRI superconducting magnet cooling and expanding semiconductor manufact...

Dimethylformamide market to reach $4.54B by 2035 driven by pharma and industrial demand growth.
The global dimethylformamide (DMF) market, valued at $2.79 billion in 2025, is projected to grow at a CAGR of 4.98% to reach $4.54 billion by 2035. Growth is fueled by expanding pharmaceutical API manufacturing, especially in India, China, and Europe...
